An article today in my local newspaper (What's in a name? Mix-ups spur FDA to do more to avoid sound-alike medications) points out that "three years ago, Johnson & Johnson changed the name of its Alzheimer's drug Reminyl because it was being confused by doctors and pharmacists with the diabetes medicine Amaryl. Mix-ups were linked to two deaths and some serious health problems for patients." This story reminded me of several hassles I've confronted with name confusion for diabetes medications.
Â...
Read more »...the standard treatment of the day: a single shot of Lente insulin in the morning and then the... Read more »
Like everyone with type 1 diabetes and almost half of the people with type 2, my wife uses insulin... Read more »
is clearly confusing. Among other reasons: The same product may have several different names;... Read more »
Around 11:15 am today, my pump died. Then I brought it back to life. At 9 pm, it died again. For... Read more »
After reviewing the healthcentral web site and diabetes related links, I noticed that questions... Read more »
(Ivanhoe Newswire) -- Type 2 diabetics and those with any kind of insulin resistance may have a new option for controlling blood sugar levels. A... Read summary »
(Ivanhoe Newswire) There's new help for young girls who are at risk of going through puberty early and developing insulin resistance a risk factor... Read summary »
(Ivanhoe Newswire) -- New research suggests using insulin to control the blood sugar of low-birth-weight infants is not worth the risks. Infants born... Read summary »
(Ivanhoe Newswire) -- A long-term study from Sweden shows men who develop diabetes in mid-life have a significantly higher chance of getting... Read summary »
Researchers identified a new source of insulin-producing cells. Results of a new study show cells in the pancreas that produce insulin -- called beta... Read summary »